urea and fosbretabulin

urea has been researched along with fosbretabulin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
C-Gaudreault, R; Fortin, S; Lacroix, J; Moreau, E; Patenaude, A; Teulade, JC1
C-Gaudreault, R; Côté, MF; Fortin, S; Gagné-Boulet, M; Lacroix, J; Lefebvre, CA1
Carda, M; Conesa-Milián, L; Falomir, E; Marco, JA; Murga, J1

Other Studies

3 other study(ies) available for urea and fosbretabulin

ArticleYear
N-Phenyl-N'-(2-chloroethyl)urea analogues of combretastatin A-4: Is the N-phenyl-N'-(2-chloroethyl)urea pharmacophore mimicking the trimethoxy phenyl moiety?
    Bioorganic & medicinal chemistry letters, 2007, Apr-01, Volume: 17, Issue:7

    Topics: Antimitotic Agents; Binding, Competitive; Cell Cycle; Cell Line, Tumor; Chemistry, Pharmaceutical; Colchicine; Drug Design; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Stilbenes; Tubulin; Urea

2007
Styryl-N-phenyl-N'-(2-chloroethyl)ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model.
    European journal of medicinal chemistry, 2015, Jul-15, Volume: 100

    Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Imidazolidines; MCF-7 Cells; Microtubules; Molecular Structure; Stilbenes; Structure-Activity Relationship; Urea

2015
Synthesis and biological evaluation as antiangiogenic agents of ureas derived from 3'-aminocombretastatin A-4.
    European journal of medicinal chemistry, 2019, Jan-15, Volume: 162

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Stilbenes; Urea; Vascular Endothelial Growth Factor Receptor-2

2019